Novo Nordisk
NVO
NVO
559 hedge funds and large institutions have $8.89B invested in Novo Nordisk in 2019 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 190 increasing their positions, 195 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 580 → 559 (-21)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
23% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 69
Holders
559
Holding in Top 10
8
Calls
$56.2M
Puts
$24.4M
Top Buyers
| 1 | +$98M | |
| 2 | +$60.1M | |
| 3 | +$49.2M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$46.4M |
| 5 |
Jennison Associates
New York
|
+$29.7M |
Top Sellers
| 1 | -$101M | |
| 2 | -$94M | |
| 3 | -$43.5M | |
| 4 |
BlackRock
New York
|
-$29.9M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$22.6M |